| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liposomes | 109 | 2014 | 710 | 4.210 |
Why?
|
| Amphotericin B | 49 | 2005 | 304 | 3.160 |
Why?
|
| RNA, Small Interfering | 52 | 2014 | 2218 | 3.120 |
Why?
|
| Ovarian Neoplasms | 57 | 2015 | 4795 | 2.820 |
Why?
|
| Tretinoin | 23 | 2013 | 621 | 1.630 |
Why?
|
| Drug Carriers | 38 | 2013 | 336 | 1.430 |
Why?
|
| Gene Silencing | 24 | 2014 | 832 | 1.420 |
Why?
|
| Nanoparticles | 11 | 2014 | 586 | 1.340 |
Why?
|
| RNA Interference | 16 | 2014 | 1397 | 1.070 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 7 | 2014 | 163 | 1.040 |
Why?
|
| Leukemia, Promyelocytic, Acute | 11 | 2013 | 439 | 1.010 |
Why?
|
| Mice, Nude | 42 | 2015 | 4358 | 1.010 |
Why?
|
| Transglutaminases | 11 | 2008 | 100 | 1.000 |
Why?
|
| Drug Delivery Systems | 14 | 2013 | 662 | 0.990 |
Why?
|
| Candidiasis | 21 | 2005 | 281 | 0.990 |
Why?
|
| Cell Line, Tumor | 69 | 2014 | 14868 | 0.980 |
Why?
|
| Monocytes | 23 | 2014 | 788 | 0.950 |
Why?
|
| Neoplasms, Glandular and Epithelial | 9 | 2014 | 522 | 0.930 |
Why?
|
| Receptor, EphA2 | 6 | 2013 | 139 | 0.910 |
Why?
|
| Oligonucleotides, Antisense | 12 | 2011 | 257 | 0.890 |
Why?
|
| Animals | 157 | 2015 | 62757 | 0.890 |
Why?
|
| Gene Expression Regulation, Neoplastic | 43 | 2014 | 9093 | 0.880 |
Why?
|
| Mice | 112 | 2015 | 36006 | 0.820 |
Why?
|
| Nystatin | 8 | 2005 | 11 | 0.790 |
Why?
|
| Macrophages | 19 | 2015 | 1376 | 0.780 |
Why?
|
| Down-Regulation | 22 | 2014 | 2105 | 0.780 |
Why?
|
| Taxoids | 6 | 2014 | 1010 | 0.770 |
Why?
|
| Neovascularization, Pathologic | 17 | 2014 | 1599 | 0.750 |
Why?
|
| Autophagy | 8 | 2014 | 921 | 0.720 |
Why?
|
| Genetic Therapy | 14 | 2011 | 1732 | 0.710 |
Why?
|
| Antineoplastic Agents | 38 | 2014 | 14653 | 0.700 |
Why?
|
| Drug Resistance, Neoplasm | 18 | 2013 | 5420 | 0.680 |
Why?
|
| Apoptosis | 30 | 2014 | 7834 | 0.680 |
Why?
|
| Lipoproteins | 7 | 1997 | 232 | 0.610 |
Why?
|
| Cell Proliferation | 35 | 2014 | 7292 | 0.610 |
Why?
|
| Norepinephrine | 6 | 2015 | 285 | 0.590 |
Why?
|
| Cisplatin | 10 | 2014 | 2497 | 0.580 |
Why?
|
| MicroRNAs | 12 | 2014 | 2912 | 0.580 |
Why?
|
| Receptor, ErbB-2 | 10 | 2012 | 2649 | 0.580 |
Why?
|
| Protein Kinase C-delta | 2 | 2007 | 42 | 0.570 |
Why?
|
| Antifungal Agents | 11 | 2003 | 876 | 0.540 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 9 | 2008 | 1547 | 0.540 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2011 | 2624 | 0.530 |
Why?
|
| Humans | 209 | 2016 | 271636 | 0.530 |
Why?
|
| Pancreatic Neoplasms | 6 | 2014 | 5246 | 0.520 |
Why?
|
| Xenograft Model Antitumor Assays | 21 | 2014 | 3924 | 0.520 |
Why?
|
| Organoplatinum Compounds | 7 | 2005 | 704 | 0.510 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 4 | 2007 | 44 | 0.510 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2014 | 196 | 0.500 |
Why?
|
| Breast Neoplasms | 25 | 2014 | 16226 | 0.490 |
Why?
|
| Receptors, Notch | 3 | 2014 | 377 | 0.490 |
Why?
|
| Troponin C | 1 | 2014 | 24 | 0.490 |
Why?
|
| Contractile Proteins | 1 | 2014 | 44 | 0.480 |
Why?
|
| Carcinoma | 9 | 2015 | 2623 | 0.480 |
Why?
|
| Signal Transduction | 26 | 2014 | 12219 | 0.470 |
Why?
|
| Neoplasms | 22 | 2016 | 15903 | 0.470 |
Why?
|
| Epinephrine | 3 | 2015 | 249 | 0.470 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2014 | 78 | 0.470 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 203 | 0.470 |
Why?
|
| Pentoxifylline | 7 | 1996 | 37 | 0.450 |
Why?
|
| Bridged-Ring Compounds | 2 | 2011 | 180 | 0.450 |
Why?
|
| Glucose Oxidase | 1 | 2013 | 1 | 0.450 |
Why?
|
| Phosphatidylcholines | 12 | 2013 | 129 | 0.450 |
Why?
|
| Platinum | 3 | 2012 | 143 | 0.440 |
Why?
|
| Phosphofructokinase-1, Type C | 1 | 2013 | 21 | 0.440 |
Why?
|
| Glycoproteins | 4 | 2014 | 792 | 0.440 |
Why?
|
| Leukemia, Myeloid | 8 | 2007 | 994 | 0.430 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2001 | 1482 | 0.430 |
Why?
|
| Biosensing Techniques | 1 | 2013 | 82 | 0.420 |
Why?
|
| Transcription Factors | 11 | 2014 | 5504 | 0.420 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2014 | 672 | 0.420 |
Why?
|
| Female | 109 | 2015 | 148992 | 0.420 |
Why?
|
| Receptors, Peptide | 2 | 2009 | 88 | 0.420 |
Why?
|
| Tumor Cells, Cultured | 27 | 2013 | 5804 | 0.410 |
Why?
|
| Diphosphonates | 1 | 2014 | 264 | 0.410 |
Why?
|
| Tumor Necrosis Factor-alpha | 10 | 2000 | 1613 | 0.400 |
Why?
|
| Stress, Psychological | 3 | 2015 | 1038 | 0.390 |
Why?
|
| Neuralgia | 2 | 2012 | 264 | 0.390 |
Why?
|
| Nociception | 1 | 2011 | 47 | 0.390 |
Why?
|
| Up-Regulation | 6 | 2011 | 2457 | 0.390 |
Why?
|
| Endothelial Cells | 6 | 2013 | 1047 | 0.390 |
Why?
|
| Doxorubicin | 4 | 2012 | 3131 | 0.380 |
Why?
|
| Aldehyde Dehydrogenase | 2 | 2011 | 108 | 0.380 |
Why?
|
| Apoptosis Regulatory Proteins | 7 | 2014 | 620 | 0.380 |
Why?
|
| Base Sequence | 15 | 2014 | 5499 | 0.370 |
Why?
|
| Magnetics | 1 | 2011 | 99 | 0.370 |
Why?
|
| Cell Division | 14 | 2013 | 2711 | 0.370 |
Why?
|
| Lipoproteins, HDL | 4 | 1994 | 132 | 0.360 |
Why?
|
| Receptors, Cell Surface | 4 | 2012 | 911 | 0.360 |
Why?
|
| Calcium Channels | 1 | 2011 | 214 | 0.360 |
Why?
|
| Proteins | 5 | 2001 | 2057 | 0.360 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2011 | 202 | 0.360 |
Why?
|
| Adrenergic Agents | 1 | 2010 | 21 | 0.360 |
Why?
|
| Sensory Receptor Cells | 1 | 2011 | 155 | 0.350 |
Why?
|
| Anoikis | 1 | 2010 | 63 | 0.350 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2009 | 46 | 0.350 |
Why?
|
| Nanocapsules | 1 | 2010 | 28 | 0.350 |
Why?
|
| Kidney | 17 | 1999 | 2265 | 0.350 |
Why?
|
| Calcium-Binding Proteins | 2 | 2014 | 557 | 0.340 |
Why?
|
| Cell Survival | 16 | 2014 | 3075 | 0.340 |
Why?
|
| Mycoses | 11 | 1997 | 396 | 0.340 |
Why?
|
| Membrane Proteins | 7 | 2014 | 2973 | 0.330 |
Why?
|
| Immunohistochemistry | 19 | 2014 | 7817 | 0.330 |
Why?
|
| Nuclear Proteins | 9 | 2014 | 3472 | 0.320 |
Why?
|
| RNA, Messenger | 17 | 2016 | 6488 | 0.320 |
Why?
|
| Receptors, Retinoic Acid | 6 | 2006 | 374 | 0.320 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2010 | 156 | 0.320 |
Why?
|
| Antigens, CD | 3 | 2012 | 1436 | 0.320 |
Why?
|
| Paclitaxel | 3 | 2014 | 2099 | 0.310 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2008 | 60 | 0.310 |
Why?
|
| Rats | 23 | 2012 | 6633 | 0.310 |
Why?
|
| Lipids | 4 | 2010 | 662 | 0.310 |
Why?
|
| Adrenomedullin | 1 | 2009 | 107 | 0.310 |
Why?
|
| Cell Differentiation | 13 | 2014 | 4191 | 0.310 |
Why?
|
| Hyperlipidemias | 1 | 2010 | 237 | 0.310 |
Why?
|
| Adenovirus E1A Proteins | 5 | 2001 | 165 | 0.310 |
Why?
|
| DNA Repair | 3 | 2014 | 1912 | 0.310 |
Why?
|
| HL-60 Cells | 7 | 2008 | 318 | 0.310 |
Why?
|
| Transcription Factor RelA | 1 | 2008 | 185 | 0.310 |
Why?
|
| Promoter Regions, Genetic | 3 | 2003 | 3262 | 0.310 |
Why?
|
| Genetic Vectors | 3 | 2013 | 1883 | 0.310 |
Why?
|
| Macrophage Activation | 10 | 1991 | 151 | 0.300 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 771 | 0.290 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2005 | 212 | 0.290 |
Why?
|
| ErbB Receptors | 3 | 2001 | 2383 | 0.290 |
Why?
|
| Transplantation, Heterologous | 10 | 2012 | 1086 | 0.290 |
Why?
|
| Polycomb Repressive Complex 2 | 3 | 2014 | 160 | 0.290 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2010 | 461 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-akt | 12 | 2012 | 2085 | 0.280 |
Why?
|
| Lipopolysaccharides | 9 | 2000 | 593 | 0.270 |
Why?
|
| Tissue Distribution | 14 | 2013 | 946 | 0.270 |
Why?
|
| Hyperthermia, Induced | 1 | 2011 | 510 | 0.270 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2008 | 704 | 0.270 |
Why?
|
| Cyclosporine | 3 | 1992 | 296 | 0.270 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 5067 | 0.260 |
Why?
|
| Genes, bcl-2 | 3 | 2002 | 174 | 0.260 |
Why?
|
| Neuregulin-1 | 3 | 2014 | 89 | 0.260 |
Why?
|
| Piperazines | 3 | 2009 | 2151 | 0.260 |
Why?
|
| Liver Neoplasms | 6 | 2013 | 4805 | 0.260 |
Why?
|
| Neoplastic Stem Cells | 2 | 2011 | 1469 | 0.260 |
Why?
|
| Neoplasm Metastasis | 10 | 2014 | 5328 | 0.260 |
Why?
|
| WT1 Proteins | 2 | 2003 | 108 | 0.260 |
Why?
|
| Kidney Diseases | 8 | 1997 | 731 | 0.250 |
Why?
|
| Organophosphorus Compounds | 2 | 1996 | 94 | 0.250 |
Why?
|
| Carrier Proteins | 3 | 2014 | 2138 | 0.250 |
Why?
|
| Transfection | 11 | 2014 | 3165 | 0.250 |
Why?
|
| Phosphatidylglycerols | 7 | 1997 | 32 | 0.250 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2014 | 1824 | 0.250 |
Why?
|
| GRB2 Adaptor Protein | 5 | 2007 | 56 | 0.250 |
Why?
|
| Oxides | 5 | 2009 | 212 | 0.240 |
Why?
|
| Arsenicals | 5 | 2009 | 204 | 0.240 |
Why?
|
| src-Family Kinases | 4 | 2013 | 487 | 0.240 |
Why?
|
| Fusion Proteins, bcr-abl | 6 | 2007 | 1143 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 15 | 2013 | 5102 | 0.240 |
Why?
|
| Cystadenocarcinoma, Serous | 3 | 2013 | 499 | 0.240 |
Why?
|
| Disease Models, Animal | 17 | 2014 | 7463 | 0.230 |
Why?
|
| Acetylmuramyl-Alanyl-Isoglutamine | 7 | 1986 | 57 | 0.230 |
Why?
|
| Anti-Bacterial Agents | 4 | 2011 | 3171 | 0.230 |
Why?
|
| Stromal Cells | 3 | 2014 | 835 | 0.230 |
Why?
|
| Fenretinide | 1 | 2004 | 100 | 0.230 |
Why?
|
| Fat Emulsions, Intravenous | 2 | 1994 | 72 | 0.230 |
Why?
|
| Cytotoxins | 5 | 1986 | 65 | 0.220 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2013 | 487 | 0.220 |
Why?
|
| Chitosan | 4 | 2011 | 85 | 0.220 |
Why?
|
| Cell Line | 14 | 2013 | 5431 | 0.220 |
Why?
|
| Silicon | 3 | 2013 | 48 | 0.220 |
Why?
|
| Deoxycytidine | 1 | 2008 | 1378 | 0.220 |
Why?
|
| Granulocytes | 3 | 2008 | 243 | 0.210 |
Why?
|
| Cell Movement | 11 | 2014 | 2503 | 0.210 |
Why?
|
| Leukemia L1210 | 5 | 1990 | 57 | 0.210 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 7 | 1997 | 2634 | 0.210 |
Why?
|
| Ligands | 3 | 2013 | 1057 | 0.210 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2008 | 1346 | 0.200 |
Why?
|
| Pyrimidines | 3 | 2009 | 3663 | 0.200 |
Why?
|
| Oligonucleotides | 4 | 2013 | 245 | 0.200 |
Why?
|
| Blotting, Western | 11 | 2013 | 3646 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2007 | 682 | 0.200 |
Why?
|
| Candida albicans | 8 | 1994 | 188 | 0.200 |
Why?
|
| DNA Primers | 5 | 2010 | 1513 | 0.200 |
Why?
|
| In Vitro Techniques | 12 | 2011 | 1742 | 0.200 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 1997 | 591 | 0.190 |
Why?
|
| Lipoproteins, LDL | 4 | 1994 | 151 | 0.190 |
Why?
|
| Interferon-gamma | 14 | 1991 | 1180 | 0.190 |
Why?
|
| Co-Repressor Proteins | 2 | 2012 | 120 | 0.190 |
Why?
|
| Polymers | 3 | 2011 | 223 | 0.190 |
Why?
|
| STAT3 Transcription Factor | 1 | 2007 | 1146 | 0.180 |
Why?
|
| Nanotechnology | 2 | 2013 | 137 | 0.180 |
Why?
|
| Drug Synergism | 7 | 2014 | 1364 | 0.180 |
Why?
|
| Theobromine | 2 | 1990 | 3 | 0.180 |
Why?
|
| Cell Membrane | 4 | 2013 | 900 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 14 | 2013 | 3651 | 0.180 |
Why?
|
| Pleural Neoplasms | 1 | 2005 | 487 | 0.180 |
Why?
|
| Interleukin-6 | 3 | 2012 | 1066 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 2174 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2014 | 1294 | 0.180 |
Why?
|
| Neuropilin-2 | 2 | 2011 | 21 | 0.180 |
Why?
|
| GTP-Binding Proteins | 5 | 2008 | 347 | 0.170 |
Why?
|
| Bone Marrow Cells | 3 | 2000 | 981 | 0.170 |
Why?
|
| Mesothelioma | 1 | 2005 | 560 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 8 | 2014 | 1085 | 0.170 |
Why?
|
| Cells, Cultured | 17 | 2011 | 5779 | 0.170 |
Why?
|
| Retinoids | 4 | 1987 | 151 | 0.170 |
Why?
|
| Blood | 1 | 2000 | 172 | 0.170 |
Why?
|
| Actins | 2 | 2014 | 616 | 0.170 |
Why?
|
| Aspergillosis | 4 | 1997 | 249 | 0.170 |
Why?
|
| Interleukin-8 | 3 | 2013 | 531 | 0.160 |
Why?
|
| Gene Expression | 10 | 2014 | 3688 | 0.160 |
Why?
|
| Receptors, Muscarinic | 2 | 2009 | 72 | 0.160 |
Why?
|
| Cytotoxicity, Immunologic | 9 | 1991 | 683 | 0.160 |
Why?
|
| Tumor Burden | 7 | 2014 | 2035 | 0.160 |
Why?
|
| Splenic Diseases | 3 | 1993 | 59 | 0.160 |
Why?
|
| Adenosine Triphosphatases | 2 | 2013 | 428 | 0.160 |
Why?
|
| Drug Compounding | 4 | 2013 | 73 | 0.160 |
Why?
|
| Proto-Oncogenes | 2 | 1991 | 208 | 0.160 |
Why?
|
| Liver | 9 | 1999 | 3123 | 0.160 |
Why?
|
| Colonic Neoplasms | 3 | 2005 | 1443 | 0.160 |
Why?
|
| Neoplasm Transplantation | 10 | 2014 | 1566 | 0.160 |
Why?
|
| Rats, Inbred Strains | 8 | 1992 | 483 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 6 | 2012 | 4495 | 0.160 |
Why?
|
| Benzopyrans | 3 | 2007 | 42 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 7 | 2010 | 4963 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2000 | 177 | 0.160 |
Why?
|
| Drug Design | 2 | 2013 | 378 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 9 | 2014 | 4070 | 0.150 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 223 | 0.150 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2014 | 1004 | 0.150 |
Why?
|
| Protein Transport | 4 | 2011 | 739 | 0.150 |
Why?
|
| Retinoic Acid Receptor alpha | 5 | 2006 | 95 | 0.150 |
Why?
|
| Male | 55 | 2014 | 128836 | 0.150 |
Why?
|
| Protein Biosynthesis | 5 | 1997 | 1035 | 0.150 |
Why?
|
| Acetophenones | 2 | 2007 | 23 | 0.150 |
Why?
|
| Lymphoma, Follicular | 2 | 2003 | 636 | 0.140 |
Why?
|
| RNA-Binding Proteins | 2 | 2008 | 1021 | 0.140 |
Why?
|
| Erythrocytes | 7 | 1996 | 340 | 0.140 |
Why?
|
| Rabbits | 3 | 2010 | 1077 | 0.140 |
Why?
|
| Anti-Infective Agents | 3 | 1995 | 465 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2012 | 2252 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 7 | 2015 | 6266 | 0.130 |
Why?
|
| Phosphorylation | 7 | 2013 | 4984 | 0.130 |
Why?
|
| Thionucleotides | 1 | 1996 | 67 | 0.130 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2011 | 624 | 0.130 |
Why?
|
| Models, Biological | 6 | 2013 | 3223 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 1532 | 0.130 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2016 | 57 | 0.130 |
Why?
|
| Prognosis | 12 | 2014 | 22525 | 0.130 |
Why?
|
| Antibodies, Blocking | 2 | 2006 | 92 | 0.130 |
Why?
|
| Drug Stability | 2 | 2013 | 108 | 0.130 |
Why?
|
| Adult | 32 | 2014 | 81791 | 0.130 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 3 | 2014 | 263 | 0.130 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2002 | 382 | 0.130 |
Why?
|
| Spinal Cord | 2 | 2009 | 724 | 0.130 |
Why?
|
| Serrate-Jagged Proteins | 2 | 2014 | 85 | 0.130 |
Why?
|
| Glutaminase | 1 | 2016 | 71 | 0.130 |
Why?
|
| Retinoic Acid 4-Hydroxylase | 2 | 2005 | 17 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2007 | 490 | 0.130 |
Why?
|
| Vitamin A | 3 | 1990 | 91 | 0.120 |
Why?
|
| Beclin-1 | 3 | 2014 | 89 | 0.120 |
Why?
|
| Enzyme Inhibitors | 5 | 2009 | 1965 | 0.120 |
Why?
|
| Jagged-1 Protein | 2 | 2014 | 103 | 0.120 |
Why?
|
| Interferon Type I | 2 | 1990 | 283 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2013 | 259 | 0.120 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1999 | 685 | 0.120 |
Why?
|
| Repressor Proteins | 2 | 2014 | 1730 | 0.120 |
Why?
|
| Deoxycholic Acid | 2 | 1994 | 24 | 0.120 |
Why?
|
| Injections, Intravenous | 6 | 2001 | 596 | 0.120 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2015 | 161 | 0.120 |
Why?
|
| Hematologic Diseases | 1 | 1996 | 255 | 0.120 |
Why?
|
| Gramicidin | 3 | 1989 | 5 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2010 | 133 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 4 | 2013 | 2398 | 0.120 |
Why?
|
| Gastrointestinal Stromal Tumors | 2 | 2007 | 318 | 0.120 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2014 | 26 | 0.120 |
Why?
|
| Particle Size | 2 | 2013 | 187 | 0.120 |
Why?
|
| Macrophages, Peritoneal | 1 | 1994 | 76 | 0.120 |
Why?
|
| Receptors, Prolactin | 1 | 2014 | 29 | 0.120 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2014 | 97 | 0.120 |
Why?
|
| Nitric Oxide | 3 | 1996 | 665 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2013 | 1574 | 0.120 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2013 | 16 | 0.120 |
Why?
|
| Cations | 2 | 2011 | 60 | 0.120 |
Why?
|
| Leukemia | 5 | 1997 | 1721 | 0.110 |
Why?
|
| Biomarkers, Tumor | 5 | 2014 | 10743 | 0.110 |
Why?
|
| Cytarabine | 1 | 2000 | 2014 | 0.110 |
Why?
|
| Receptor, EphB2 | 1 | 2013 | 21 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 1212 | 0.110 |
Why?
|
| Prolactin | 1 | 2014 | 174 | 0.110 |
Why?
|
| Enzymes, Immobilized | 1 | 2013 | 12 | 0.110 |
Why?
|
| Glutaral | 1 | 2013 | 16 | 0.110 |
Why?
|
| Omentum | 1 | 2014 | 107 | 0.110 |
Why?
|
| Prostatic Neoplasms | 6 | 2013 | 5996 | 0.110 |
Why?
|
| Infusions, Intravenous | 6 | 2005 | 1439 | 0.110 |
Why?
|
| Adenocarcinoma | 7 | 2014 | 7971 | 0.110 |
Why?
|
| Osteoclasts | 1 | 2014 | 158 | 0.110 |
Why?
|
| Enzyme Stability | 1 | 2013 | 110 | 0.110 |
Why?
|
| Complement System Proteins | 1 | 2014 | 136 | 0.110 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2014 | 107 | 0.110 |
Why?
|
| Phosphates | 1 | 2014 | 194 | 0.110 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2013 | 28 | 0.110 |
Why?
|
| Glutamic Acid | 2 | 2012 | 335 | 0.110 |
Why?
|
| Kallikreins | 1 | 2013 | 86 | 0.110 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 339 | 0.110 |
Why?
|
| Endoglin | 1 | 2012 | 41 | 0.110 |
Why?
|
| Ganglia, Spinal | 2 | 2011 | 255 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 3 | 2010 | 782 | 0.110 |
Why?
|
| Albumins | 1 | 2014 | 267 | 0.110 |
Why?
|
| Philadelphia Chromosome | 1 | 1997 | 834 | 0.110 |
Why?
|
| Treatment Outcome | 12 | 2014 | 33846 | 0.110 |
Why?
|
| Cross-Linking Reagents | 1 | 2013 | 167 | 0.110 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2002 | 557 | 0.110 |
Why?
|
| Vasoconstrictor Agents | 2 | 2010 | 166 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2013 | 102 | 0.100 |
Why?
|
| Kinetics | 9 | 2007 | 2242 | 0.100 |
Why?
|
| Disease Progression | 8 | 2013 | 6905 | 0.100 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 1134 | 0.100 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2012 | 56 | 0.100 |
Why?
|
| Middle Aged | 29 | 2014 | 90349 | 0.100 |
Why?
|
| Calpain | 1 | 2012 | 71 | 0.100 |
Why?
|
| Communicable Diseases | 1 | 1995 | 210 | 0.100 |
Why?
|
| Elongation Factor 2 Kinase | 1 | 2012 | 44 | 0.100 |
Why?
|
| Chlorides | 1 | 2012 | 139 | 0.100 |
Why?
|
| Glutamine | 1 | 2014 | 328 | 0.100 |
Why?
|
| Osteoporosis | 1 | 2014 | 236 | 0.100 |
Why?
|
| Mice, Inbred Strains | 8 | 1997 | 570 | 0.100 |
Why?
|
| Polyenes | 3 | 2003 | 37 | 0.100 |
Why?
|
| Crk-Associated Substrate Protein | 1 | 2011 | 27 | 0.100 |
Why?
|
| Energy Metabolism | 2 | 2016 | 1003 | 0.100 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2011 | 30 | 0.100 |
Why?
|
| Lymphoma | 6 | 2002 | 1514 | 0.100 |
Why?
|
| Symporters | 1 | 2012 | 105 | 0.100 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 247 | 0.100 |
Why?
|
| Blood Platelets | 2 | 2013 | 684 | 0.100 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2012 | 84 | 0.100 |
Why?
|
| Microdissection | 1 | 2011 | 86 | 0.100 |
Why?
|
| Melanoma | 5 | 2011 | 5591 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2013 | 319 | 0.100 |
Why?
|
| Stress, Physiological | 2 | 2013 | 494 | 0.100 |
Why?
|
| Acute Disease | 3 | 2007 | 2510 | 0.100 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2011 | 115 | 0.090 |
Why?
|
| Liver Diseases | 2 | 1987 | 605 | 0.090 |
Why?
|
| Histone Demethylases | 1 | 2012 | 145 | 0.090 |
Why?
|
| Caco-2 Cells | 1 | 2011 | 161 | 0.090 |
Why?
|
| Enzyme Activation | 4 | 2013 | 1832 | 0.090 |
Why?
|
| Microscopy, Electron | 2 | 2010 | 734 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2012 | 744 | 0.090 |
Why?
|
| Biological Assay | 1 | 2012 | 182 | 0.090 |
Why?
|
| Mesoderm | 1 | 2013 | 397 | 0.090 |
Why?
|
| Freeze Fracturing | 1 | 2010 | 5 | 0.090 |
Why?
|
| Unilamellar Liposomes | 1 | 2010 | 4 | 0.090 |
Why?
|
| Gene Expression Profiling | 6 | 2013 | 5180 | 0.090 |
Why?
|
| Thrombocytosis | 1 | 2012 | 142 | 0.090 |
Why?
|
| Ethers | 1 | 2010 | 13 | 0.090 |
Why?
|
| Cyclosporins | 1 | 1990 | 115 | 0.090 |
Why?
|
| Injections, Intra-Arterial | 1 | 2010 | 55 | 0.090 |
Why?
|
| Dimyristoylphosphatidylcholine | 5 | 1993 | 11 | 0.090 |
Why?
|
| Rhodamines | 1 | 2010 | 48 | 0.090 |
Why?
|
| Posterior Horn Cells | 1 | 2011 | 129 | 0.090 |
Why?
|
| beta Catenin | 2 | 2011 | 691 | 0.090 |
Why?
|
| Cell Separation | 4 | 1986 | 616 | 0.090 |
Why?
|
| Receptor, EphB4 | 1 | 2010 | 28 | 0.090 |
Why?
|
| Alkynes | 1 | 2010 | 30 | 0.090 |
Why?
|
| Calcium | 2 | 2014 | 1594 | 0.090 |
Why?
|
| Retinal Dehydrogenase | 1 | 2010 | 88 | 0.090 |
Why?
|
| Body Fluids | 1 | 2011 | 124 | 0.090 |
Why?
|
| Hydrogels | 1 | 2011 | 126 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2011 | 1719 | 0.090 |
Why?
|
| Connective Tissue | 1 | 2010 | 37 | 0.090 |
Why?
|
| Centrosome | 1 | 2010 | 107 | 0.090 |
Why?
|
| Spindle Apparatus | 1 | 2010 | 112 | 0.090 |
Why?
|
| ras Proteins | 1 | 2014 | 802 | 0.090 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2010 | 91 | 0.090 |
Why?
|
| Glycolysis | 1 | 2013 | 534 | 0.090 |
Why?
|
| Aged, 80 and over | 10 | 2014 | 31032 | 0.090 |
Why?
|
| Superoxides | 4 | 1986 | 222 | 0.090 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 619 | 0.090 |
Why?
|
| Opportunistic Infections | 2 | 1992 | 237 | 0.090 |
Why?
|
| Recombinant Proteins | 8 | 1999 | 3070 | 0.090 |
Why?
|
| Hormones | 1 | 2011 | 292 | 0.090 |
Why?
|
| Receptors, Adrenomedullin | 1 | 2009 | 25 | 0.090 |
Why?
|
| Agranulocytosis | 2 | 1992 | 83 | 0.090 |
Why?
|
| Androgens | 1 | 2013 | 553 | 0.090 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2012 | 801 | 0.090 |
Why?
|
| Disease-Free Survival | 6 | 2013 | 10259 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2014 | 4370 | 0.090 |
Why?
|
| Homeostasis | 2 | 2012 | 959 | 0.090 |
Why?
|
| Nanomedicine | 1 | 2010 | 53 | 0.090 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 135 | 0.090 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2012 | 269 | 0.090 |
Why?
|
| Peroxiredoxins | 1 | 2009 | 18 | 0.080 |
Why?
|
| Receptors, LDL | 3 | 1994 | 123 | 0.080 |
Why?
|
| Aged | 19 | 2014 | 73421 | 0.080 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2009 | 104 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 280 | 0.080 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2014 | 640 | 0.080 |
Why?
|
| Relaxin | 1 | 2009 | 22 | 0.080 |
Why?
|
| Acetylcholine | 1 | 2009 | 107 | 0.080 |
Why?
|
| Dopamine | 1 | 2011 | 341 | 0.080 |
Why?
|
| Carcinoid Tumor | 1 | 2011 | 282 | 0.080 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2002 | 370 | 0.080 |
Why?
|
| Ionophores | 1 | 1989 | 24 | 0.080 |
Why?
|
| Neutropenia | 4 | 1997 | 1001 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 2 | 1992 | 1773 | 0.080 |
Why?
|
| Coronary Stenosis | 1 | 2010 | 93 | 0.080 |
Why?
|
| Nucleotidases | 1 | 1988 | 10 | 0.080 |
Why?
|
| Neoplasms, Experimental | 5 | 2014 | 790 | 0.080 |
Why?
|
| Phospholipids | 2 | 2009 | 170 | 0.080 |
Why?
|
| DNA Damage | 2 | 2012 | 1989 | 0.080 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2008 | 48 | 0.080 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2008 | 20 | 0.080 |
Why?
|
| Antibodies, Neoplasm | 2 | 2010 | 275 | 0.080 |
Why?
|
| Nucleoside Deaminases | 1 | 1988 | 45 | 0.080 |
Why?
|
| Receptor, PAR-1 | 1 | 2008 | 32 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 1990 | 207 | 0.080 |
Why?
|
| Drug Administration Schedule | 4 | 2005 | 3538 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2011 | 1842 | 0.080 |
Why?
|
| Hedgehog Proteins | 1 | 2011 | 441 | 0.080 |
Why?
|
| Hydrogen Peroxide | 2 | 1986 | 225 | 0.080 |
Why?
|
| Gold | 1 | 2010 | 266 | 0.080 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 160 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 882 | 0.080 |
Why?
|
| Adenosine Deaminase | 1 | 1988 | 113 | 0.080 |
Why?
|
| Antigens, Differentiation | 2 | 2006 | 253 | 0.080 |
Why?
|
| Mitochondria | 4 | 2013 | 1313 | 0.080 |
Why?
|
| Molecular Sequence Data | 6 | 1996 | 6781 | 0.080 |
Why?
|
| Colorectal Neoplasms | 3 | 2008 | 3697 | 0.080 |
Why?
|
| Killer Cells, Natural | 2 | 2002 | 959 | 0.080 |
Why?
|
| Cholesterol | 4 | 2003 | 681 | 0.080 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1990 | 238 | 0.080 |
Why?
|
| Kupffer Cells | 1 | 1988 | 41 | 0.080 |
Why?
|
| Endoribonucleases | 1 | 2008 | 111 | 0.080 |
Why?
|
| Cation Transport Proteins | 1 | 2009 | 172 | 0.080 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2008 | 95 | 0.080 |
Why?
|
| G1 Phase | 2 | 2013 | 306 | 0.080 |
Why?
|
| Gene Expression Regulation | 6 | 2014 | 4193 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2010 | 450 | 0.080 |
Why?
|
| HCT116 Cells | 3 | 2016 | 354 | 0.080 |
Why?
|
| Mice, Inbred ICR | 5 | 2007 | 246 | 0.070 |
Why?
|
| Eukaryotic Cells | 1 | 2007 | 51 | 0.070 |
Why?
|
| Leukemia, Experimental | 1 | 2007 | 83 | 0.070 |
Why?
|
| Cell Growth Processes | 3 | 2014 | 339 | 0.070 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2002 | 475 | 0.070 |
Why?
|
| Colorimetry | 1 | 1987 | 31 | 0.070 |
Why?
|
| Genes, myc | 1 | 2009 | 375 | 0.070 |
Why?
|
| Ribonuclease III | 1 | 2008 | 188 | 0.070 |
Why?
|
| Protein Kinases | 2 | 2010 | 919 | 0.070 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 143 | 0.070 |
Why?
|
| Emodin | 1 | 2007 | 15 | 0.070 |
Why?
|
| Peritoneal Neoplasms | 1 | 2014 | 852 | 0.070 |
Why?
|
| Fibroins | 1 | 2007 | 20 | 0.070 |
Why?
|
| Plateletpheresis | 2 | 1986 | 11 | 0.070 |
Why?
|
| Hyperalgesia | 1 | 2009 | 244 | 0.070 |
Why?
|
| Drug Interactions | 4 | 2008 | 584 | 0.070 |
Why?
|
| Heart Diseases | 2 | 2011 | 739 | 0.070 |
Why?
|
| Matrix Metalloproteinases | 1 | 2007 | 139 | 0.070 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2007 | 87 | 0.070 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2008 | 286 | 0.070 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2008 | 191 | 0.070 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2008 | 262 | 0.070 |
Why?
|
| Leishmaniasis, Visceral | 1 | 1986 | 24 | 0.070 |
Why?
|
| Adenosine Triphosphate | 2 | 2013 | 593 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2007 | 320 | 0.070 |
Why?
|
| Antiprotozoal Agents | 1 | 1986 | 41 | 0.070 |
Why?
|
| Renal Circulation | 3 | 1992 | 65 | 0.070 |
Why?
|
| Blood Physiological Phenomena | 1 | 1986 | 8 | 0.070 |
Why?
|
| Hemodynamics | 1 | 1991 | 973 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2005 | 1740 | 0.070 |
Why?
|
| Tuftsin | 1 | 1986 | 1 | 0.070 |
Why?
|
| Cell Death | 3 | 2014 | 689 | 0.070 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2007 | 207 | 0.070 |
Why?
|
| Centrifugation | 1 | 1986 | 65 | 0.070 |
Why?
|
| Morpholines | 1 | 2007 | 296 | 0.070 |
Why?
|
| Sinusitis | 1 | 1987 | 148 | 0.070 |
Why?
|
| Isomerism | 1 | 2005 | 67 | 0.070 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 532 | 0.070 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2006 | 126 | 0.060 |
Why?
|
| Response Elements | 1 | 2006 | 200 | 0.060 |
Why?
|
| Guidelines as Topic | 1 | 2007 | 371 | 0.060 |
Why?
|
| Genome, Human | 2 | 2011 | 1878 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2010 | 643 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 709 | 0.060 |
Why?
|
| Transcription, Genetic | 6 | 2013 | 3416 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 486 | 0.060 |
Why?
|
| Cyclin D1 | 3 | 2012 | 591 | 0.060 |
Why?
|
| Lung Diseases | 1 | 1991 | 755 | 0.060 |
Why?
|
| Cadherins | 3 | 2014 | 676 | 0.060 |
Why?
|
| Lung | 4 | 2009 | 3293 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 896 | 0.060 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2012 | 1236 | 0.060 |
Why?
|
| Protein Binding | 4 | 2009 | 3526 | 0.060 |
Why?
|
| Cell Hypoxia | 3 | 2011 | 352 | 0.060 |
Why?
|
| Escherichia coli | 1 | 2011 | 1308 | 0.060 |
Why?
|
| Neuroendocrine Tumors | 1 | 2011 | 651 | 0.060 |
Why?
|
| Sarcoma, Kaposi | 2 | 2002 | 192 | 0.060 |
Why?
|
| Rats, Inbred Lew | 3 | 2007 | 119 | 0.060 |
Why?
|
| Time Factors | 10 | 2014 | 13116 | 0.060 |
Why?
|
| Thoracoscopy | 1 | 2005 | 103 | 0.060 |
Why?
|
| Sarcoidosis | 1 | 1985 | 115 | 0.060 |
Why?
|
| Heart | 1 | 2011 | 1214 | 0.060 |
Why?
|
| Swine | 3 | 2010 | 1610 | 0.060 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2004 | 42 | 0.060 |
Why?
|
| Cytokines | 2 | 2001 | 2837 | 0.060 |
Why?
|
| Rats, Inbred F344 | 2 | 1994 | 238 | 0.060 |
Why?
|
| Sterols | 2 | 1984 | 23 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2011 | 1890 | 0.060 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 2005 | 181 | 0.060 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2006 | 504 | 0.060 |
Why?
|
| Phagocytosis | 4 | 1986 | 296 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 1992 | 780 | 0.060 |
Why?
|
| Neoplasm Grading | 3 | 2013 | 1827 | 0.060 |
Why?
|
| Bone Neoplasms | 3 | 2014 | 2668 | 0.060 |
Why?
|
| DNA Methylation | 2 | 2012 | 2759 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2012 | 300 | 0.060 |
Why?
|
| Oncogenes | 1 | 1987 | 701 | 0.060 |
Why?
|
| Spleen | 6 | 1999 | 732 | 0.060 |
Why?
|
| Random Allocation | 3 | 2010 | 746 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 2128 | 0.060 |
Why?
|
| Neoplasm Staging | 5 | 2013 | 13989 | 0.060 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2004 | 157 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2011 | 910 | 0.050 |
Why?
|
| Probability | 1 | 2005 | 887 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 3 | 1992 | 603 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2011 | 1073 | 0.050 |
Why?
|
| Binding Sites | 2 | 2009 | 2298 | 0.050 |
Why?
|
| Thymidine Kinase | 1 | 2004 | 224 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2012 | 1588 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2011 | 1142 | 0.050 |
Why?
|
| Chickens | 1 | 2004 | 791 | 0.050 |
Why?
|
| Immunoblastic Lymphadenopathy | 1 | 1983 | 30 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 1988 | 252 | 0.050 |
Why?
|
| Peritoneal Cavity | 3 | 2001 | 58 | 0.050 |
Why?
|
| Vimentin | 2 | 2014 | 260 | 0.050 |
Why?
|
| Immunoglobulin Fragments | 1 | 2002 | 27 | 0.050 |
Why?
|
| Antigens, Neoplasm | 2 | 2006 | 1589 | 0.050 |
Why?
|
| Temperature | 2 | 1994 | 540 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 1984 | 264 | 0.050 |
Why?
|
| Benzamides | 4 | 2012 | 1882 | 0.050 |
Why?
|
| Oxygen | 2 | 1985 | 800 | 0.050 |
Why?
|
| HIV Infections | 2 | 1997 | 2156 | 0.050 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 1995 | 582 | 0.050 |
Why?
|
| Surface Properties | 2 | 2009 | 187 | 0.050 |
Why?
|
| Cells | 1 | 2001 | 37 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2006 | 3934 | 0.050 |
Why?
|
| Lymphocytes | 2 | 1985 | 1280 | 0.050 |
Why?
|
| Immunocompromised Host | 3 | 1997 | 721 | 0.050 |
Why?
|
| Ki-67 Antigen | 3 | 2011 | 685 | 0.050 |
Why?
|
| Follow-Up Studies | 5 | 2013 | 15254 | 0.050 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2001 | 58 | 0.050 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1987 | 1068 | 0.050 |
Why?
|
| Biological Transport | 3 | 2012 | 645 | 0.050 |
Why?
|
| src Homology Domains | 1 | 2001 | 133 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2005 | 1401 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2003 | 422 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2002 | 621 | 0.050 |
Why?
|
| Cholesterol, HDL | 2 | 1994 | 371 | 0.050 |
Why?
|
| Tumor Microenvironment | 4 | 2014 | 2999 | 0.050 |
Why?
|
| Nitrites | 2 | 1991 | 69 | 0.050 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2000 | 20 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2002 | 7244 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 2 | 1998 | 380 | 0.050 |
Why?
|
| Drug Combinations | 4 | 2006 | 634 | 0.050 |
Why?
|
| Technetium | 3 | 1985 | 80 | 0.050 |
Why?
|
| Enzyme Induction | 4 | 1988 | 262 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2003 | 549 | 0.040 |
Why?
|
| Chromatography, Gel | 2 | 1993 | 161 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 384 | 0.040 |
Why?
|
| Fusarium | 2 | 1993 | 57 | 0.040 |
Why?
|
| Remission Induction | 4 | 2013 | 3645 | 0.040 |
Why?
|
| Lung Neoplasms | 5 | 2013 | 12008 | 0.040 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1995 | 123 | 0.040 |
Why?
|
| Tissue Array Analysis | 2 | 2012 | 759 | 0.040 |
Why?
|
| Muscarinic Agonists | 2 | 2009 | 42 | 0.040 |
Why?
|
| Cell Adhesion | 3 | 2009 | 1041 | 0.040 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 2 | 2011 | 170 | 0.040 |
Why?
|
| Organ Size | 2 | 2014 | 727 | 0.040 |
Why?
|
| Adolescent | 9 | 2013 | 32609 | 0.040 |
Why?
|
| Cholesterol, LDL | 2 | 1994 | 583 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2011 | 611 | 0.040 |
Why?
|
| Fluorescent Dyes | 2 | 2013 | 468 | 0.040 |
Why?
|
| Genes, Viral | 1 | 1999 | 257 | 0.040 |
Why?
|
| Structure-Activity Relationship | 3 | 2011 | 1005 | 0.040 |
Why?
|
| Culture Media | 2 | 1991 | 338 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 2 | 1990 | 241 | 0.040 |
Why?
|
| Plasmacytoma | 1 | 1999 | 123 | 0.040 |
Why?
|
| Bone Marrow | 3 | 2001 | 2431 | 0.040 |
Why?
|
| Cell Cycle | 3 | 2014 | 2150 | 0.040 |
Why?
|
| Capsules | 2 | 1987 | 54 | 0.040 |
Why?
|
| Recurrence | 5 | 2001 | 4884 | 0.040 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2014 | 895 | 0.040 |
Why?
|
| DNA, Antisense | 1 | 1997 | 44 | 0.040 |
Why?
|
| Candida | 3 | 1987 | 170 | 0.040 |
Why?
|
| Neurons | 1 | 2008 | 2459 | 0.040 |
Why?
|
| Obesity | 1 | 1990 | 2952 | 0.040 |
Why?
|
| Antibody Specificity | 2 | 2010 | 340 | 0.040 |
Why?
|
| Genes, abl | 1 | 1997 | 120 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 1999 | 445 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2011 | 6876 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2010 | 3852 | 0.040 |
Why?
|
| Phagocytes | 1 | 1997 | 43 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2013 | 9323 | 0.040 |
Why?
|
| Aspergillus fumigatus | 1 | 1997 | 138 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2011 | 532 | 0.030 |
Why?
|
| Immunoprecipitation | 2 | 2008 | 593 | 0.030 |
Why?
|
| Survival Rate | 2 | 2013 | 12530 | 0.030 |
Why?
|
| Proteomics | 1 | 2004 | 1436 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 2495 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 1996 | 49 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2013 | 2365 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 1998 | 485 | 0.030 |
Why?
|
| Gene Transfer Techniques | 2 | 2014 | 812 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 7222 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2012 | 860 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2016 | 125 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2013 | 1755 | 0.030 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 1011 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2010 | 2334 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2011 | 16606 | 0.030 |
Why?
|
| Protein Kinase C | 2 | 2014 | 419 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2008 | 3077 | 0.030 |
Why?
|
| Parabiosis | 1 | 2014 | 14 | 0.030 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 2 | 1986 | 88 | 0.030 |
Why?
|
| Cholesterol Esters | 1 | 1994 | 20 | 0.030 |
Why?
|
| Activating Transcription Factor 1 | 1 | 1994 | 21 | 0.030 |
Why?
|
| Skin Neoplasms | 2 | 2014 | 4888 | 0.030 |
Why?
|
| Oxygen Consumption | 2 | 1987 | 423 | 0.030 |
Why?
|
| Administration, Metronomic | 1 | 2014 | 15 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1997 | 764 | 0.030 |
Why?
|
| Interleukin-2 | 2 | 2006 | 890 | 0.030 |
Why?
|
| Genes, MHC Class I | 2 | 1991 | 49 | 0.030 |
Why?
|
| Exudates and Transudates | 1 | 1994 | 57 | 0.030 |
Why?
|
| Apolipoprotein A-I | 1 | 1994 | 101 | 0.030 |
Why?
|
| Receptor, Notch3 | 1 | 2014 | 32 | 0.030 |
Why?
|
| Ascitic Fluid | 1 | 1994 | 86 | 0.030 |
Why?
|
| Receptors, Lipoprotein | 1 | 1994 | 14 | 0.030 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 1994 | 71 | 0.030 |
Why?
|
| Body Weight | 2 | 1990 | 1334 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 337 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 1994 | 119 | 0.030 |
Why?
|
| Neoplasm Proteins | 5 | 2010 | 3363 | 0.030 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2014 | 167 | 0.030 |
Why?
|
| Dynamins | 1 | 2014 | 78 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 1984 | 172 | 0.030 |
Why?
|
| Fluorescence | 1 | 1994 | 199 | 0.030 |
Why?
|
| Receptor, ErbB-3 | 1 | 2014 | 126 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2003 | 2471 | 0.030 |
Why?
|
| Complement Activation | 1 | 2014 | 95 | 0.030 |
Why?
|
| Platelet Count | 2 | 2012 | 491 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2013 | 1264 | 0.030 |
Why?
|
| Mutation | 4 | 2008 | 15913 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2014 | 140 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 2 | 1996 | 1372 | 0.030 |
Why?
|
| R-SNARE Proteins | 1 | 2013 | 19 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 217 | 0.030 |
Why?
|
| Qa-SNARE Proteins | 1 | 2013 | 42 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2013 | 123 | 0.030 |
Why?
|
| Fungi | 2 | 1985 | 148 | 0.030 |
Why?
|
| Endocytosis | 1 | 2014 | 239 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2014 | 325 | 0.030 |
Why?
|
| Phosphoproteins | 2 | 2014 | 1230 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1996 | 718 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1990 | 727 | 0.030 |
Why?
|
| Imatinib Mesylate | 2 | 2007 | 1690 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2014 | 372 | 0.030 |
Why?
|
| Phosphoserine | 1 | 2013 | 109 | 0.030 |
Why?
|
| Pargyline | 1 | 2012 | 3 | 0.030 |
Why?
|
| Snail Family Transcription Factors | 1 | 2013 | 122 | 0.030 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2012 | 64 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2007 | 1120 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 4352 | 0.030 |
Why?
|
| Trichosporon | 1 | 1992 | 16 | 0.030 |
Why?
|
| Genes, src | 1 | 2012 | 28 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2014 | 433 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 613 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 437 | 0.030 |
Why?
|
| Pericytes | 1 | 2013 | 91 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1994 | 388 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2013 | 154 | 0.030 |
Why?
|
| Injections, Subcutaneous | 2 | 1990 | 344 | 0.030 |
Why?
|
| Hepatitis | 1 | 1993 | 94 | 0.030 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2013 | 289 | 0.030 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2014 | 238 | 0.030 |
Why?
|
| Transgenes | 1 | 2014 | 589 | 0.030 |
Why?
|
| Exons | 1 | 1996 | 1388 | 0.030 |
Why?
|
| Cyclopropanes | 1 | 2012 | 89 | 0.030 |
Why?
|
| omega-N-Methylarginine | 1 | 1991 | 34 | 0.030 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2012 | 67 | 0.020 |
Why?
|
| Proteolysis | 1 | 2013 | 379 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2005 | 3539 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2013 | 404 | 0.020 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2011 | 53 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2012 | 83 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2014 | 770 | 0.020 |
Why?
|
| Carcinogenicity Tests | 1 | 2011 | 70 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2012 | 364 | 0.020 |
Why?
|
| CTLA-4 Antigen | 2 | 2006 | 681 | 0.020 |
Why?
|
| Thrombopoietin | 1 | 2012 | 102 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2012 | 231 | 0.020 |
Why?
|
| Hodgkin Disease | 3 | 1985 | 1488 | 0.020 |
Why?
|
| Adenoviridae | 1 | 1997 | 1510 | 0.020 |
Why?
|
| Electrolytes | 1 | 2011 | 64 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1991 | 45 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2002 | 185 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2014 | 636 | 0.020 |
Why?
|
| Receptors, Dopamine | 1 | 2011 | 52 | 0.020 |
Why?
|
| Tyrosine | 1 | 2013 | 509 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 215 | 0.020 |
Why?
|
| Epigenomics | 1 | 2012 | 267 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2002 | 16943 | 0.020 |
Why?
|
| Phenotype | 2 | 2013 | 6510 | 0.020 |
Why?
|
| Cholesterol, VLDL | 1 | 1991 | 18 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2012 | 5113 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 245 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2011 | 190 | 0.020 |
Why?
|
| Antibodies | 1 | 1994 | 819 | 0.020 |
Why?
|
| Idarubicin | 2 | 2006 | 459 | 0.020 |
Why?
|
| Drug Evaluation | 2 | 1990 | 435 | 0.020 |
Why?
|
| Carcinogens | 1 | 2012 | 398 | 0.020 |
Why?
|
| Child | 5 | 2013 | 30401 | 0.020 |
Why?
|
| HeLa Cells | 1 | 1994 | 1717 | 0.020 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2011 | 87 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1209 | 0.020 |
Why?
|
| Protein Stability | 1 | 2011 | 376 | 0.020 |
Why?
|
| Trans-Activators | 2 | 2012 | 1660 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1997 | 935 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2013 | 330 | 0.020 |
Why?
|
| Rats, Zucker | 1 | 1990 | 60 | 0.020 |
Why?
|
| Antioxidants | 1 | 2013 | 523 | 0.020 |
Why?
|
| Tosyllysine Chloromethyl Ketone | 1 | 1990 | 2 | 0.020 |
Why?
|
| Blood Cells | 1 | 1990 | 130 | 0.020 |
Why?
|
| Microvessels | 1 | 2011 | 141 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2010 | 50 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 261 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 532 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 271 | 0.020 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2009 | 21 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2009 | 57 | 0.020 |
Why?
|
| Muscarine | 1 | 2009 | 17 | 0.020 |
Why?
|
| Leukocyte Count | 2 | 2007 | 738 | 0.020 |
Why?
|
| Mortality | 1 | 2002 | 353 | 0.020 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 2009 | 24 | 0.020 |
Why?
|
| Receptor, Muscarinic M4 | 1 | 2009 | 21 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2012 | 326 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 352 | 0.020 |
Why?
|
| Vaccines | 1 | 1995 | 396 | 0.020 |
Why?
|
| Necrosis | 1 | 2011 | 604 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2011 | 304 | 0.020 |
Why?
|
| Copper-transporting ATPases | 1 | 2009 | 44 | 0.020 |
Why?
|
| Platinum Compounds | 1 | 2009 | 129 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 702 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2009 | 30 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 2598 | 0.020 |
Why?
|
| Membranes, Artificial | 1 | 2009 | 39 | 0.020 |
Why?
|
| Diffusion | 1 | 2009 | 96 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2009 | 57 | 0.020 |
Why?
|
| Erythrocyte Membrane | 1 | 1989 | 38 | 0.020 |
Why?
|
| Oxotremorine | 1 | 2008 | 24 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2009 | 59 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1994 | 1496 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 1486 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 399 | 0.020 |
Why?
|
| Injections, Spinal | 1 | 2009 | 275 | 0.020 |
Why?
|
| Anthracenes | 1 | 2008 | 47 | 0.020 |
Why?
|
| Nickel | 1 | 2008 | 45 | 0.020 |
Why?
|
| Cadmium | 1 | 2008 | 47 | 0.020 |
Why?
|
| Anisotropy | 1 | 2009 | 186 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2010 | 190 | 0.020 |
Why?
|
| Glutathione | 1 | 2011 | 377 | 0.020 |
Why?
|
| Autoradiography | 1 | 2008 | 158 | 0.020 |
Why?
|
| Biophysics | 1 | 2008 | 116 | 0.020 |
Why?
|
| Mammals | 1 | 2010 | 374 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2009 | 245 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 678 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2009 | 197 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2008 | 114 | 0.020 |
Why?
|
| DNA Adducts | 1 | 2009 | 214 | 0.020 |
Why?
|
| 5'-Nucleotidase | 1 | 1988 | 63 | 0.020 |
Why?
|
| Arginine | 1 | 1991 | 509 | 0.020 |
Why?
|
| Acyltransferases | 2 | 1985 | 67 | 0.020 |
Why?
|
| Nanostructures | 1 | 2009 | 101 | 0.020 |
Why?
|
| Caspases | 1 | 2011 | 687 | 0.020 |
Why?
|
| Autophagy-Related Protein 8 Family | 1 | 2007 | 4 | 0.020 |
Why?
|
| Antibodies, Viral | 2 | 2002 | 1295 | 0.020 |
Why?
|
| Estrogens | 1 | 2012 | 844 | 0.020 |
Why?
|
| Cardiotoxins | 1 | 2007 | 16 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2009 | 512 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 1987 | 119 | 0.020 |
Why?
|
| Semaphorins | 1 | 2008 | 37 | 0.020 |
Why?
|
| Synapses | 1 | 2012 | 556 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2008 | 160 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 2008 | 164 | 0.020 |
Why?
|
| Ion Channel Gating | 1 | 2008 | 151 | 0.020 |
Why?
|
| Polarography | 1 | 1987 | 1 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2002 | 954 | 0.020 |
Why?
|
| Microchemistry | 1 | 1987 | 11 | 0.020 |
Why?
|
| Electron Transport Complex II | 1 | 1987 | 4 | 0.020 |
Why?
|
| Quinone Reductases | 1 | 1987 | 7 | 0.020 |
Why?
|
| Monokines | 1 | 1987 | 15 | 0.020 |
Why?
|
| Phagosomes | 1 | 2007 | 72 | 0.020 |
Why?
|
| Methods | 1 | 1987 | 223 | 0.020 |
Why?
|
| Cadaverine | 1 | 1987 | 7 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2008 | 398 | 0.020 |
Why?
|
| Potassium | 1 | 1989 | 349 | 0.020 |
Why?
|
| Prostaglandins E | 1 | 1987 | 23 | 0.020 |
Why?
|
| Plants | 1 | 2007 | 63 | 0.020 |
Why?
|
| Collodion | 1 | 1987 | 16 | 0.020 |
Why?
|
| Electron Transport | 1 | 1987 | 83 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2013 | 909 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2008 | 491 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 1990 | 243 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2012 | 845 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 1133 | 0.020 |
Why?
|
| Microcirculation | 1 | 2008 | 194 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2003 | 1618 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2007 | 286 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 1987 | 233 | 0.020 |
Why?
|
| Pyrroles | 1 | 2011 | 592 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2008 | 122 | 0.020 |
Why?
|
| Succinate Dehydrogenase | 1 | 1987 | 49 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 278 | 0.020 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 1987 | 60 | 0.020 |
Why?
|
| Pharmaceutical Vehicles | 1 | 1986 | 14 | 0.020 |
Why?
|
| Phytohemagglutinins | 2 | 1985 | 73 | 0.020 |
Why?
|
| K562 Cells | 1 | 2007 | 345 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2007 | 205 | 0.020 |
Why?
|
| Collagen | 1 | 2010 | 737 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2010 | 417 | 0.020 |
Why?
|
| Sirolimus | 1 | 2011 | 833 | 0.020 |
Why?
|
| Leishmania donovani | 1 | 1986 | 24 | 0.020 |
Why?
|
| Terbutaline | 1 | 2006 | 30 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1997 | 1736 | 0.020 |
Why?
|
| Mesocricetus | 1 | 1986 | 119 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 1987 | 168 | 0.020 |
Why?
|
| Retinol-Binding Proteins | 1 | 1986 | 31 | 0.020 |
Why?
|
| Bucladesine | 1 | 1986 | 32 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1986 | 55 | 0.020 |
Why?
|
| Immune Sera | 1 | 1986 | 146 | 0.020 |
Why?
|
| Isoproterenol | 1 | 2006 | 135 | 0.020 |
Why?
|
| Saimiri | 1 | 1986 | 120 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 1987 | 227 | 0.020 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1986 | 51 | 0.020 |
Why?
|
| Dinoprostone | 1 | 1987 | 222 | 0.020 |
Why?
|
| Homosexuality | 1 | 1985 | 30 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2007 | 569 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2012 | 1649 | 0.020 |
Why?
|
| MART-1 Antigen | 1 | 2005 | 113 | 0.020 |
Why?
|
| Indoles | 1 | 2011 | 1034 | 0.020 |
Why?
|
| Cricetinae | 1 | 1986 | 793 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 2672 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2001 | 4136 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 1074 | 0.020 |
Why?
|
| Virus Replication | 1 | 1989 | 761 | 0.020 |
Why?
|
| Equipment Design | 1 | 2009 | 1206 | 0.020 |
Why?
|
| Glucose | 1 | 2011 | 1242 | 0.020 |
Why?
|
| Folic Acid | 1 | 2008 | 371 | 0.020 |
Why?
|
| Transcriptome | 1 | 2014 | 1940 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1997 | 3670 | 0.020 |
Why?
|
| Lymphoscintigraphy | 1 | 1985 | 35 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 1438 | 0.020 |
Why?
|
| Histones | 1 | 2012 | 1513 | 0.020 |
Why?
|
| Histoplasmosis | 1 | 1985 | 80 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 22094 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 1995 | 83 | 0.020 |
Why?
|
| HIV-1 | 1 | 1989 | 641 | 0.010 |
Why?
|
| Cell Line, Transformed | 2 | 1999 | 431 | 0.010 |
Why?
|
| Peptide Elongation Factors | 1 | 2004 | 17 | 0.010 |
Why?
|
| RNA | 2 | 1986 | 1069 | 0.010 |
Why?
|
| Peptide Initiation Factors | 1 | 2004 | 50 | 0.010 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2004 | 51 | 0.010 |
Why?
|
| Phthalazines | 1 | 2006 | 263 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2007 | 472 | 0.010 |
Why?
|
| Ethyl Ethers | 1 | 2003 | 2 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 2267 | 0.010 |
Why?
|
| Receptors, Fc | 1 | 1984 | 72 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2007 | 1278 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2004 | 210 | 0.010 |
Why?
|
| Pain | 1 | 2012 | 1696 | 0.010 |
Why?
|
| Fibrosarcoma | 1 | 1984 | 142 | 0.010 |
Why?
|
| Mucormycosis | 1 | 1985 | 118 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2006 | 482 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 815 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2006 | 385 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 2 | 2002 | 617 | 0.010 |
Why?
|
| Graft vs Host Reaction | 1 | 1983 | 62 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 1892 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2005 | 431 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2008 | 1198 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1985 | 718 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 2006 | 493 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 2365 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2005 | 595 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 6230 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2003 | 321 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2005 | 1587 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 5838 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 4635 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2005 | 433 | 0.010 |
Why?
|
| Radiography | 1 | 2006 | 1991 | 0.010 |
Why?
|
| Lymphocyte Activation | 2 | 1985 | 1728 | 0.010 |
Why?
|
| Lysosomes | 1 | 1984 | 346 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 144 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 449 | 0.010 |
Why?
|
| Injections | 1 | 2001 | 288 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 9467 | 0.010 |
Why?
|
| Genes, erbB-2 | 1 | 2001 | 228 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1990 | 735 | 0.010 |
Why?
|
| Thorax | 1 | 2001 | 230 | 0.010 |
Why?
|
| Cancer Vaccines | 1 | 2005 | 751 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 5744 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1990 | 265 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1986 | 1444 | 0.010 |
Why?
|
| Terpenes | 1 | 1999 | 40 | 0.010 |
Why?
|
| Risk Factors | 2 | 2011 | 18016 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 4391 | 0.010 |
Why?
|
| Pyridines | 1 | 2006 | 1311 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1999 | 455 | 0.010 |
Why?
|
| Histone Deacetylases | 1 | 2001 | 366 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 277 | 0.010 |
Why?
|
| Estradiol | 1 | 2002 | 881 | 0.010 |
Why?
|
| Biopsy | 1 | 1986 | 3544 | 0.010 |
Why?
|
| Tamoxifen | 1 | 2002 | 906 | 0.010 |
Why?
|
| Leishmaniasis, Mucocutaneous | 1 | 1997 | 1 | 0.010 |
Why?
|
| Dosage Forms | 1 | 1997 | 11 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1999 | 758 | 0.010 |
Why?
|
| Chromans | 1 | 1997 | 29 | 0.010 |
Why?
|
| Telomerase | 1 | 2001 | 542 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1997 | 387 | 0.010 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 1997 | 70 | 0.010 |
Why?
|
| Half-Life | 1 | 1997 | 269 | 0.010 |
Why?
|
| Nitriles | 1 | 2002 | 943 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2002 | 848 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1997 | 209 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2003 | 13385 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1997 | 250 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1999 | 832 | 0.010 |
Why?
|
| Benzoates | 1 | 1997 | 130 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 13887 | 0.010 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 1999 | 621 | 0.010 |
Why?
|
| Renal Artery Obstruction | 1 | 1996 | 41 | 0.010 |
Why?
|
| Area Under Curve | 1 | 1997 | 729 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 1999 | 817 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 1154 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 1997 | 674 | 0.010 |
Why?
|
| Safety | 1 | 1997 | 466 | 0.010 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1996 | 121 | 0.010 |
Why?
|
| Texas | 1 | 2006 | 6434 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1999 | 2468 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 1994 | 161 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 6208 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 1994 | 181 | 0.010 |
Why?
|
| Aerosols | 1 | 1994 | 149 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1999 | 3512 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1993 | 178 | 0.010 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1993 | 72 | 0.010 |
Why?
|
| Ischemia | 1 | 1996 | 403 | 0.010 |
Why?
|
| Chorioretinitis | 1 | 1992 | 3 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1992 | 44 | 0.010 |
Why?
|
| Antigens, Fungal | 1 | 1992 | 44 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1992 | 107 | 0.010 |
Why?
|
| Asparaginase | 1 | 1993 | 186 | 0.010 |
Why?
|
| Dermatomycoses | 1 | 1992 | 41 | 0.010 |
Why?
|
| Choroid | 1 | 1992 | 44 | 0.010 |
Why?
|
| DNA | 1 | 2001 | 3088 | 0.010 |
Why?
|
| Digestive System | 1 | 1992 | 121 | 0.010 |
Why?
|
| Daunorubicin | 1 | 1993 | 313 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2005 | 3150 | 0.010 |
Why?
|
| Granuloma | 1 | 1993 | 159 | 0.010 |
Why?
|
| Lung Diseases, Fungal | 1 | 1992 | 133 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 10354 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1986 | 7788 | 0.010 |
Why?
|
| Prednisone | 1 | 1993 | 1037 | 0.010 |
Why?
|
| Complement Fixation Tests | 1 | 1989 | 37 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1989 | 71 | 0.010 |
Why?
|
| Vincristine | 1 | 1993 | 1572 | 0.000 |
Why?
|
| Quality of Life | 1 | 2002 | 4745 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1990 | 483 | 0.000 |
Why?
|
| Skin | 1 | 1992 | 1284 | 0.000 |
Why?
|
| Whole-Body Counting | 1 | 1985 | 25 | 0.000 |
Why?
|
| Ergosterol | 1 | 1985 | 9 | 0.000 |
Why?
|
| Polymyxin B | 1 | 1986 | 57 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1989 | 1139 | 0.000 |
Why?
|
| Skin Tests | 1 | 1985 | 102 | 0.000 |
Why?
|
| Splenic Neoplasms | 1 | 1985 | 125 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1985 | 289 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1985 | 658 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1985 | 386 | 0.000 |
Why?
|
| Hemolysis | 1 | 1984 | 127 | 0.000 |
Why?
|
| Dogs | 1 | 1985 | 1169 | 0.000 |
Why?
|
| Iodoacetates | 1 | 1982 | 8 | 0.000 |
Why?
|
| Cytochalasin B | 1 | 1982 | 15 | 0.000 |
Why?
|
| Cell Communication | 1 | 1985 | 518 | 0.000 |
Why?
|
| Deoxyglucose | 1 | 1982 | 124 | 0.000 |
Why?
|
| Multiple Myeloma | 1 | 1986 | 2286 | 0.000 |
Why?
|